PLASMA CELL LEUKEMIA
Clinical trials for PLASMA CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for PLASMA CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug dose test halted before starting
Disease control TerminatedThis early-stage study aimed to find the safest and most effective dose of the chemotherapy drug bendamustine for people with multiple myeloma who had been treated before. Researchers planned to give increasing doses to small groups of patients to see how much they could tolerate…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Lab test picks Cancer's poison in hope for tough myeloma cases
Disease control OngoingThis study is testing a new, personalized method for treating multiple myeloma that has returned or stopped responding to standard drugs. Doctors take a sample of a patient's cancer cells and test many different drugs on them in the lab to see which ones work best. The goal is to…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug aims to tame dangerous immune storms after cancer transplants
Disease control OngoingThis early-stage study is testing whether a drug called itacitinib can make stem cell transplants safer for older patients with blood cancers. The goal is to prevent a severe, potentially life-threatening immune reaction called cytokine release syndrome (CRS) that can occur after…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Trial aims to ease debilitating side effect for cancer patients
Symptom relief TerminatedThis study is testing whether a drug called budesonide can prevent or reduce severe diarrhea in people with multiple myeloma who are undergoing a stem cell transplant. About 120 participants will be randomly assigned to receive either budesonide or a placebo, in addition to their…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Mar 20, 2026 14:48 UTC